Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma
- PMID: 4930209
- PMCID: PMC1796103
- DOI: 10.1136/bmj.2.5757.305
Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma
Abstract
A microculture technique has been adapted to assay the cytotoxic properties of the lymphocytes from patients with malignant melanoma when cultured with their autologous tumour cells. In a series of patients with established melanoma specific autologous cytotoxicity was extremely uncommon, being detectable in only 3 out of the 22 cases studied. This cytotoxicity did not correlate with clinical staging of the disease but may well have been related to tumour volume. By autoimmunization of patients with an irradiated suspension of their own tumour cells the appearance of cytotoxic lymphocytes could be provoked in 5 out of the 12 patients studied. This cytotoxicity was detectable at the end of the first week after the autograft and disappeared by the third week. Cytotoxic lymphocytes did not correlate in any obvious way with the appearance of specific antitumour antibodies detected by immunofluorescence. So far there has been no evidence of a serum factor capable of blocking the lymphocyte cytotoxicity in these patients.The presence and possible significance of cytotoxic lymphocytes in patients with malignant disease is discussed.
Similar articles
-
Autoimmunization with irradiated tumour cells in human malignant melanoma.Br Med J. 1970 Jun 27;2(5712):752-4. doi: 10.1136/bmj.2.5712.752. Br Med J. 1970. PMID: 4913783 Free PMC article.
-
Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.Br J Cancer. 1972 Dec;26(6):427-38. doi: 10.1038/bjc.1972.59. Br J Cancer. 1972. PMID: 4119105 Free PMC article.
-
Effect of autoimmunization with irradiated tumour cells on specific cell-mediated immunity in patients with malignant melanoma.Proc R Soc Med. 1972 Feb;65(2):144-7. doi: 10.1177/003591577206500210. Proc R Soc Med. 1972. PMID: 4563684 Free PMC article. No abstract available.
-
Tumour-associated antigens and tumour-host interactions.Proc R Soc Med. 1971 Oct;64(10):1039-42. doi: 10.1177/003591577106401013. Proc R Soc Med. 1971. PMID: 4335921 Free PMC article. Review. No abstract available.
-
Host factors in human malignant melanoma.Pathol Annu. 1971;6:171-95. Pathol Annu. 1971. PMID: 4949366 Review. No abstract available.
Cited by
-
Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.Br J Cancer. 1976 Aug;34(2):116-33. doi: 10.1038/bjc.1976.134. Br J Cancer. 1976. PMID: 962991 Free PMC article.
-
Histological evidence of tumour rejection after active immunotherapy in human malignant disease.Br Med J. 1972 Apr 22;2(5807):183-8. doi: 10.1136/bmj.2.5807.183. Br Med J. 1972. PMID: 4336763 Free PMC article.
-
Immune therapy of malignant melanoma.Can Med Assoc J. 1972 Sep 9;107(5):390-1. Can Med Assoc J. 1972. PMID: 4561532 Free PMC article. No abstract available.
-
The role of circulating antigen as an inhibitor of tumour immunity in man.Br J Cancer Suppl. 1973 Aug;1:153-61. Br J Cancer Suppl. 1973. PMID: 4804278 Free PMC article. No abstract available.
-
The influence of tumour burden and therapy on cellular cytotoxicity responses in patients with ocular and skin melanoma.Br J Cancer. 1975 Mar;31(3):301-16. doi: 10.1038/bjc.1975.65. Br J Cancer. 1975. PMID: 1156516 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources